Impact of a Pharmaceutical Consultation at Hospital Discharge on Adherence to Anti-infective Treatment After Returning Home
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 174
- 试验地点
- 2
- 主要终点
- The presence/absence of treatment non-adherence
研究概览
简要总结
The main objective of this study is to evaluate the impact of a pharmaceutical consultation at the time of hospital discharge on the adherence of patients ; non-adherence is determined by the following criteria:
As concerns prescribed anti-infectious treatments, at least one of the following 4 criteria is true:
- . the patient did not go and get his/her treatment at the pharmacy;
- . the number of treatment units dispensed by the pharmacy is < the number of treatment units prescribed;
- . the patient stopped taking a treatment before the recommended time, or continued taking a treatment after the recommended time;
- . the number of treatment units taken by the patient (self-declaration) is < or > to the number of units prescribed.
详细描述
The secondary objectives of this study are :
A- To assess the percentage of patients who obtained their anti- infective pharmaceuticals
B- To evaluate the ratio of the number of units of anti- infective drugs dispensed by the pharmacy over the number of units of anti- infective drugs prescribed
C- To determine the ratio of the number of premature discontinuations of anti -infective treatments over the number of lines of anti -infective treatments prescribed
D- Evaluate the ratio of the number of units actually taken by the patient (based on a self-declaration) over the number of units of anti- infective drugs prescribed
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Prevention
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •The patient must have given his/her informed and signed consent
- •The patient must be insured or beneficiary of a health insurance plan
- •The patient is hospitalized in the Infectious and Tropical Diseases department of the Nîmes University Hospital, and is scheduled for hospital discharge with one or more pharmaceutical prescriptions for anti-infectious treatments
排除标准
- •The patient is participating in another study
- •The patient is in an exclusion period determined by a previous study
- •The patient is under judicial protection
- •The patient refuses to sign the consent
- •It is impossible to correctly inform the patient
- •The patient resides in a care establishment, or has home medical/nursing service
- •The patient is suffering from chronic infection (>4 weeks of treatment required)
- •The patient is suffering from handicapping deafness, dementia, or does not have a telephone
- •Intravenous, intramuscular or subcutaneous anti-infectious treatments are prescribed
- •Prescription of antiretroviral treatments
结局指标
主要结局
The presence/absence of treatment non-adherence
时间窗: 1 week after end of treatment (expected max of 4 weeks)
As concerns prescribed anti-infectious treatments, at least one of the following 4 criteria is true: 1. . the patient did not go and get his/her treatment at the pharmacy; 2. . the number of treatment units dispensed by the pharmacy is \< the number of treatment units prescribed; 3. . the patient stopped taking a treatment before the recommended time, or continued taking a treatment after the recommended time; 4. . the number of treatment units taken by the patient (self-declaration) is \< or \> to the number of units prescribed.
次要结局
- Test for measuring overall compliance (MAQ)(Day 0 (hospital discharge))
- Satisfaction Questionnaire concerning pharmaceutical consultation(Day 0 (hospital discharge))
- Number of anti-infectious drug units dispensed by the pharmacy / number of anti-infections drug units prescribed(1 week after end of treatment (expected max of 4 weeks))
- Socio-demographic characteristics(Day 0 (hospital discharge))
- Number of premature discontinuations of anti-infective therapies / the prescribed number of anti-infective treatments(1 week after end of treatment (expected max of 4 weeks))
- Number of anti-infectious drug units taken by the patient (self-declaration) / number of anti-infections drug units prescribed(1 week after end of treatment (expected max of 4 weeks))
- Delivery of anti-infectious therapy by the pharmacy (yes/no)(1 week after end of treatment (expected max of 4 weeks))
- Quiz on anti-infective therapy comprehension(Day 0 (hospital discharge))